Lung Cancer: Low-dose CT Screening - Determining the Right Interval

Overview

Journal Nat Rev Clin Oncol

Specialty Oncology

Date 2016 Jul 13

PMID 27402578

Citations 2

Authors

David Yankelevitz

Claudia Henschke

Affiliations

Soon will be listed here.

Citing Articles

Comparison of lung cancer occurring in fibrotic versus non-fibrotic lung on chest CT.

Salvatore M, Liu Y, Peng B, Hsu H, Saqi A, Tsai W J Transl Med. 2024; 22(1):67.

PMID: 38229113 PMC: 10792886. DOI: 10.1186/s12967-023-04645-y.

Perspectives and limitations of Lung-RADS in different target populations: the power of systematic review and meta-analysis.

Vicini S Eur Radiol. 2023; 34(3):1875-1876.

PMID: 37646817 DOI: 10.1007/s00330-023-10156-7.

References

Henschke C, Yankelevitz D, Yip R, Reeves A, Farooqi A, Xu D . Lung cancers diagnosed at annual CT screening: volume doubling times. Radiology. 2012; 263(2):578-83. PMC: 3329268. DOI: 10.1148/radiol.12102489. View

Yankelevitz D, Smith J . Understanding the core result of the National Lung Screening Trial. N Engl J Med. 2013; 368(15):1460-1. DOI: 10.1056/NEJMc1213744. View

Patz Jr E, Greco E, Gatsonis C, Pinsky P, Kramer B, Aberle D . Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol. 2016; 17(5):590-9. PMC: 5094059. DOI: 10.1016/S1470-2045(15)00621-X. View

Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

Miettinen O, Henschke C, Pasmantier M, Smith J, Libby D, Yankelevitz D . Mammographic screening: no reliable supporting evidence?. Lancet. 2002; 359(9304):404-5. DOI: 10.1016/S0140-6736(02)07592-X. View